173 related articles for article (PubMed ID: 21555373)
1. The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.
Sharma AK; Kline CL; Berg A; Amin S; Irby RB
Clin Cancer Res; 2011 Jul; 17(13):4474-83. PubMed ID: 21555373
[TBL] [Abstract][Full Text] [Related]
2. The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.
Allen JE; Gallant JN; Dicker DT; Amin S; Irby RB; Sharma AK; El-Deiry WS
PLoS One; 2013; 8(3):e59380. PubMed ID: 23555026
[TBL] [Abstract][Full Text] [Related]
3. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
4. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.
Wang BD; Kline CL; Pastor DM; Olson TL; Frank B; Luu T; Sharma AK; Robertson G; Weirauch MT; Patierno SR; Stuart JM; Irby RB; Lee NH
Mol Cancer; 2010 Apr; 9():98. PubMed ID: 20433755
[TBL] [Abstract][Full Text] [Related]
5. Delivery of PAR-4 plasmid in vivo via nanoliposomes sensitizes colon tumor cells subcutaneously implanted into nude mice to 5-FU.
Kline CL; Shanmugavelandy SS; Kester M; Irby RB
Cancer Biol Ther; 2009 Oct; 8(19):1831-7. PubMed ID: 19729995
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
7. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer.
Das TP; Suman S; Alatassi H; Ankem MK; Damodaran C
Cell Death Dis; 2016 Feb; 7(2):e2111. PubMed ID: 26913603
[TBL] [Abstract][Full Text] [Related]
9. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells.
Wu W; Karelia D; Pramanik K; Amin SG; Sharma AK; Jiang C; Lu J
Mol Carcinog; 2018 Aug; 57(8):1055-1066. PubMed ID: 29668110
[TBL] [Abstract][Full Text] [Related]
12. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
Zhang Y; Talmon G; Wang J
Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730
[TBL] [Abstract][Full Text] [Related]
15. Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
Yang S; Zhu Z; Zhang X; Zhang N; Yao Z
Oncotarget; 2017 Jan; 8(4):6102-6113. PubMed ID: 28008149
[TBL] [Abstract][Full Text] [Related]
16. The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity.
Ibáñez E; Agliano A; Prior C; Nguewa P; Redrado M; González-Zubeldia I; Plano D; Palop JA; Sanmartín C; Calvo A
Curr Med Chem; 2012; 19(18):3031-43. PubMed ID: 22455594
[TBL] [Abstract][Full Text] [Related]
17. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
[TBL] [Abstract][Full Text] [Related]
18. BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
Pal I; Sarkar S; Rajput S; Dey KK; Chakraborty S; Dash R; Das SK; Sarkar D; Barile E; De SK; Pellecchia M; Fisher PB; Mandal M
Br J Cancer; 2014 Jul; 111(1):101-11. PubMed ID: 24892445
[TBL] [Abstract][Full Text] [Related]
19. Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
Nakamura Y; Hattori N; Iida N; Yamashita S; Mori A; Kimura K; Yoshino T; Ushijima T
Cancer Lett; 2017 Aug; 402():100-109. PubMed ID: 28576751
[TBL] [Abstract][Full Text] [Related]
20. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]